MyRx Care™ a leading provider of financial support services for patients, is pleased to announce the addition of Redesca®, manufactured by Valeo Pharma, to our comprehensive list of supported medications. 

"MyRx Care™ is dedicated to making healthcare more accessible and manageable for patients," said Blair Rutledge, CEO of MyRx Care™. "We are excited to onboard Redesca®  and to continue our mission of providing financial support services for patients."

With MyRx Care™'s innovative platforms, patients can now access Redesca® with ease and confidence, knowing that financial assistance may be available to help manage the costs associated with their treatment.

Key benefits of Redesca® and MyRx Care™'s support services include:

• Simple Access: MyRx Care™ streamlines the process for patients and pharmacists for access to financial assistance.
• Financial Assistance: MyRx Care™ offers financial support services at no cost for  patients..
• Peace of Mind: Patients can focus on their well-being while MyRx Care™ handles the administrative aspects of financial assistance.

As MyRx Care™ continues to expand its network of supported medications, it remains dedicated to its core values of accessibility, affordability, and patient-centric care. The addition of Redesca® to our portfolio is a testament to the company's ongoing commitment to improving the lives of individuals.

For more information about Redesca®  and the financial support services offered by MyRx Care™, please visit https://myrx.care.

About MyRx Care™:

MyRx Care™ is a leading provider of financial support services, seamless integration to patient support programs and patient adherence tools.  MyRx Care™ offers innovative, flexible, secure and scalable solutions.

For more information contact (Email) or visit https://about.myrx.care.